Media Center

CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.

Media Contact: [email protected]

California Life Sciences Announces Winners of 21st Annual Pantheon Awards

Nov 8, 2024

Celebrating the Trailblazers Advancing California’s Life Sciences Industry   FOR IMMEDIATE RELEASE: Nov 8, 2024 SAN FRANCISCO, Calif, — California Life Sciences (CLS) is thrilled to announce the winners of its..

Read More

Celebrating Innovation: Public Voting Now Open for California Life Sciences’ 21st Annual Pantheon Awards

Oct 1, 2024

FOR IMMEDIATE RELEASE: Oct 1, 2024 SAN FRANCISCO, Calif, — California Life Sciences (CLS), the state’s leading life sciences membership organization, announced today the finalists for the 2024 Pantheon Awards. The..

Read More

FAST Fall 2024 Cohort Announced

Sep 23, 2024

A dozen life sciences startups have been selected to receive 12 weeks of business mentoring from expert advisors through California Life Sciences’ advisory program, FAST California. Now in its eleventh..

Read More

CLS has Partnered with San Diego Squared (SD2)

Sep 4, 2024

CLS has partnered with San Diego Squared (SD2) to support its mission to empower historically marginalized and underserved high school and college students who have demonstrated talent in a STEM field...

Read More

California Life Sciences Announces Five New Board Members

Aug 19, 2024

San Francisco, CA – California Life Sciences (CLS), the state’s most impactful life sciences membership organization advocating for the sector and its diverse innovation pipeline, today announced five new board members..

Read More

Statement from CLS CEO, Mike Guerra, on CMS Drug Pricing

Aug 15, 2024

Following the conclusion of an arbitrary process, CMS has released the drug prices for the first ten products selected for the Medicare Drug Price Negotiation Program with cuts to list..

Read More